Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC-R): Validation of a scale to measure anxiety in men with prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; Warshowsky, A.; O'Shea, N.; Scher, H. I.; Breitbart, W.; Holland, J. C.; Curley-Smart, T.; Reynolds, T.
    Psycho-Oncology (2005)

    Fulltext@MSK | Save
  • Reverse transcriptase polymerase chain reaction for prostate-specific antigen (RT-PCR PSA) responses may predict time to progression (TTP) in hormone refractory prostate cancer (HRPC) patients treated with chemotherapy
    Meeting Abstract

    Ross, R. W.; Manola, J.; Hennessy, K.; Galsky, M.; Scher, H.; Small, E.; Kelly, W. K.; Kantoff, P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Treatment outcome and incidence for late relapse of germ cell tumor (GCT) patients (pts): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Bacik, J.; Marion, S.; Bajorin, D. F.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Age significantly influences presentation and patterns of care in patients with newly diagnosed diffuse large cell lymphoma (DLCL): Collective data from 5 centers participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project
    Meeting Abstract

    Rodriguez, M. A.; Czuczman, M. S.; Friedberg, J. W.; Kho, M. E.; LaCasce, A. S.; Millenson, M.; Auayporn, N.; Niland, J.; ter Veer, A.; Zelenetz, A. D.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC
    Meeting Abstract

    Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • The AJCC staging system does not predict survival in patients receiving multimodality therapy for esophageal cancer
    Meeting Abstract

    Rizk, N. P.; Bains, M. S.; Ilson, D. H.; Minsky, B.; Rusch, V. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • AG-013736, a multi-target tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a Phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC)
    Meeting Abstract

    Rini, B.; Rixe, O.; Bukowski, R.; Michaelson, M. D.; Wilding, G.; Hudes, G.; Bolte, O.; Steinfeldt, H.; Reich, S. D.; Motzer, R.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Variates of survival for stage IV uveal melanoma
    Meeting Abstract

    Rietschel, P.; Panageas, K.; Hanlon, C.; Patel, A.; Chapman, P. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib
    Meeting Abstract

    Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A multicenter phase II trial of bortezomib in patients with previously untreated multiple myeloma: Efficacy with manageable toxicity in patients with unexpectedly high rates of baseline peripheral neuropathy
    Meeting Abstract

    Richardson, P.; Chanan-Khan, A.; Schlossman, R.; Munshi, N.; Wen, P.; Briemberg, H.; Kuter, D.; Oaklander, A.; Lodial, S.; Hassoun, H.; more...
    Blood (2005)

    Fulltext@MSK | Save